Treatment of non-small cell lung cancer with ifosfamide (IFO)+ 4'-epiadriamycin (EPI)+platinum vs. IFO+EPI: a GETLAC Study. Grupo de Estudio y Tratamiento Latinoamericano del Cáncer Study (Q72357246)
Jump to navigation
Jump to search
scientific article published on 01 January 1995
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Treatment of non-small cell lung cancer with ifosfamide (IFO)+ 4'-epiadriamycin (EPI)+platinum vs. IFO+EPI: a GETLAC Study. Grupo de Estudio y Tratamiento Latinoamericano del Cáncer Study |
scientific article published on 01 January 1995 |
Statements
Treatment of non-small cell lung cancer with ifosfamide (IFO)+ 4'-epiadriamycin (EPI)+platinum vs. IFO+EPI: a GETLAC Study. Grupo de Estudio y Tratamiento Latinoamericano del Cáncer Study (English)
N Brocato
M F Bruno
C E Araujo
J C Cervellino
C Pirisi
G Temperley
C Sparrow
C Savulsky